PMH27 COST-EFFECTIVENESS OF DULOXETINE VS. VENLAFAXINE XRAND SSRIS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN PRIMARY AND SECONDARY CARE IN SPAIN
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65077-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65077-2/fulltext
Title :
PMH27 COST-EFFECTIVENESS OF DULOXETINE VS. VENLAFAXINE XRAND SSRIS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN PRIMARY AND SECONDARY CARE IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65077-2&doi=10.1016/S1098-3015(10)65077-2
First page :
Section Title :
Open access? :
No
Section Order :
235